In 2017, a GWAS using an exome microarray identified genome-wide significant associations between rare variants in TREM2, phospholipase C gamma 2 (PLCG2), and ABI Family Member 3 (ABI3) and AD risk [11]. Here, PLCG2 is linked to Alzheimer disease.